Development of dimethyl trisulfide (DMTS) as a non-intravenous cyanide medical countermeasure
About this Event
Dr. Gary A. Rockwood, Research Biologist with United States Army Medical Research Institute of Chemical Defense (USAMRICD), will be presenting “Development of dimethyl trisulfide (DMTS) as a non-intravenous cyanide medical countermeasure.” This seminar aims to foster an understanding of the imperative for a non-intravenous cyanide medical countermeasure and elucidate the current applications of Dimethyl Trisulfide (DMTS). Participants will delve into the safety, efficacy, and commercialization challenges of DMTS against cyanide toxicity in diverse test models.
Event Details
As a public institution of higher education, UAB adheres to principles of Free Speech, Civil Discourse and Institutional Neutrality. Freedom of Expression and Use of UAB Facilities Policy allows members of the UAB community to hold events on campus; views expressed do not represent the university, which adheres to institutional neutrality. Events held at UAB are required to comply with all applicable state and federal laws, and participation is not limited based on impermissible criteria (e.g., age, sex, race, national origin).
See Who Is Interested
0 people are interested in this event
Dial-In Information
We will be utilizing Microsoft Teams for this seminar, so please make sure that you register in advance.